Joel Baglole

Joel Baglole

Joel Baglole has been a financial reporter for more than 20 years. For five years, Mr. Baglole was a staff reporter at The Wall Street Journal, where he wrote articles from Iceland to Indonesia and covered topics ranging from the automotive and airline industries to investment banks and global stock markets.

Mr. Baglole has also worked for The Washington Post and Toronto Star newspapers, and has contributed to business focused websites such as The Motley Fool and Investopedia. At InvestorPlace, he covers a wide range of large and small cap stocks, as well as political and economic issues that impact financial markets.

Check out Joel’s TipRanks profile.

Recent Articles

Moderna Stock Could Have a Lot Further to Fall After Disasterous Earnings

Over the last five trading sessions, Moderna's stock has cratered 30%, dropping from $350 a share all the way down to $240. The steep fall came after the Cambridge, Massachusetts-based company reported disappointing quarterly results that shocked Wall Street and revised down its forward guidance.

Don’t Buy GE Stock Until Its Breakup Is Completed

General Electric's plans to break into three separate publicly traded companies creates more uncertainty for GE stock holders.

3 Sorry Stocks That You Should Dump Before Year-End

Not all stocks are created equal. While many securities have enjoyed spectacular runs this year, others have struggled and fallen steeply - underperforming the S&P 500 index's year-to-date gain of 25%. As we come to the end of 2021, it is a good time for investors to review their portfolio with an eye to culling the underperforming stocks and reallocating capital to winning securities.

Paypal Is a Long-Term Buy Despite a Bleak Q4 Forecast

Paypal's share price has been hurt by its recent earnings report, but the long-term outlook for the company and stock remain positive.

UPST Stock: Why Piper Sandler Thinks Upstart Can Return to $300 After Earnings

UPST stock is plunging after lowering its guidance, but Piper Sandler thinks Upstart is still on the right track to share-price growth.